TXNIP and cancer: Bycomparison with the findings made in Figure 2 using cancer cells, the latterresults suggest that the signaling pathways that regulate expression of Sirt1and TXNIP may be altered in cancer versus normal tissues, particularly in stemcells where only limited glucose availability was able to affect the expressionof TXNIP.